Somnair Secures $4.3M Seed Funding for Innovative Sleep Apnea Device
Somnair, founded by Johns Hopkins alumni, has raised $4.3 million to develop a non-invasive device for obstructive sleep apnea, addressing a significant unmet need for patients intolerant to traditional CPAP therapy.
Somnair, a Towson, Md.-based startup founded by Johns Hopkins alumni, has successfully raised $4.3 million in seed funding to advance the development of its innovative device aimed at managing obstructive sleep apnea. This funding round, as detailed in an SEC filing, marks a significant step forward for the company, though the investors were not disclosed. The team behind Somnair, including co-founders Anders Sideris, Mitchell Turley, Phoebe Dijour, and Shri Prabha Shivram, brings a diverse set of skills and experiences, with backgrounds in biodesign, medicine, and mechanical engineering.
The startup's mission is rooted in addressing a critical gap in sleep apnea treatment. Traditional CPAP devices, while effective, are often abandoned by patients due to discomfort and high costs. Somnair's solution is a non-invasive neurostimulation device designed to be worn in the mouth like a retainer. It targets a specific nerve to help open the airway, offering a promising alternative for the estimated 54 million Americans suffering from obstructive sleep apnea.
Early support from MedStar Health, following a pitch at Towson University’s 2024 StarTUp Accelerator, underscores the potential impact of Somnair's technology. The company's approach was inspired by extensive observation of patients and collaboration with medical professionals, leading to a device that could significantly improve quality of life for those unable to tolerate existing treatments. Preliminary studies with Johns Hopkins School of Medicine physicians have shown encouraging results, validating the device's mechanism in opening airways for CPAP-intolerant patients.
This development is not just a milestone for Somnair but also represents hope for millions seeking alternatives to manage their sleep apnea more comfortably and effectively. The intersection of innovative design, medical expertise, and patient-centric research positions Somnair as a company to watch in the healthcare technology space.